Alliancebernstein L.P. Seres Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 127,660 shares of MCRB stock, worth $91,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares

127,660

Previous 127,660 -0.0%

Holding current value

$91,915

Previous $178,000 44.94%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $54,894 - $119,449	23,560 Added 22.63%	127,660 $303,000
Q3 2022 Nov 15, 2022	BUY	$3.5 - $7.2 $39,200 - $80,640	11,200 Added 12.06%	104,100 $668,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $43,740 - $123,444	16,200 Added 21.12%	92,900 $319,000
Q1 2022 May 13, 2022	BUY	$6.3 - $8.84 $1,890 - $2,652	300 Added 0.39%	76,700 $546,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $355,180 - $674,370	-59,000 Reduced 43.57%	76,400 $636,000

Q3 2021 Nov 10, 2021	BUY	$5.46 - $22.6 $265,356 - $1.1 Million	48,600 Added 55.99%	135,400 $942,000
Q2 2021 Jul 30, 2021	BUY	$18.46 - $24.36 $142,142 - $187,572	7,700 Added 9.73%	86,800 $2.07 Million
Q1 2021 May 06, 2021	BUY	$17.66 - $28.92 $37,086 - $60,732	2,100 Added 2.73%	79,100 $1.63 Million
Q4 2020 Feb 08, 2021	BUY	$23.25 - $37.73 $313,875 - $509,354	13,500 Added 21.26%	77,000 $1.89 Million
Q3 2020 Nov 12, 2020	SELL	$3.74 - $28.74 $134,266 - $1.03 Million	-35,900 Reduced 36.12%	63,500 $1.8 Million
Q2 2020 Aug 13, 2020	BUY	$3.04 - $6.2 $52,896 - $107,880	17,400 Added 21.22%	99,400 $473,000
Q1 2020 May 14, 2020	BUY	$2.64 - $3.82 $36,960 - $53,480	14,000 Added 20.59%	82,000 $293,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $8,931 - $16,224	-3,900 Reduced 5.42%	68,000 $273,000
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $55,175 - $177,870	24,200 Added 50.73%	71,900 $232,000
Q1 2019 May 14, 2019	BUY	$4.83 - $7.21 $15,939 - $23,793	3,300 Added 7.43%	47,700 $328,000
Q4 2018 Feb 13, 2019	SELL	$4.52 - $8.88 $1,807 - $3,552	-400 Reduced 0.89%	44,400 $201,000
Q3 2018 Nov 08, 2018	BUY	$7.33 - $9.23 $10,262 - $12,922	1,400 Added 3.23%	44,800 $340,000
Q2 2018 Aug 13, 2018	BUY	$6.91 - $9.55 $13,820 - $19,100	2,000 Added 4.83%	43,400 $373,000
Q1 2018 May 14, 2018	BUY	$7.34 - $11.16 $11,010 - $16,740	1,500 Added 3.76%	41,400 $304,000
Q4 2017 Feb 13, 2018	SELL	$9.15 - $12.64 $15,555 - $21,488	-1,700 Reduced 4.09%	39,900 $405,000
Q3 2017 Nov 13, 2017	BUY	$12.81 - $16.85 $532,896 - $700,960	41,600	41,600 $667,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Seres Therapeutics, Inc. Transaction History